Ammonium chloride and tunicamycin are novel toxins for dopaminergic neurons and induce Parkinson's disease-like phenotypes in medaka fish

Journal of Neurochemistry

Volumn 115, Issue 5, 2010, Pages 1150-1160

  Matsui, Hideaki ^a   Ito, Hidefumi ^a   Taniguchi, Yoshihito ^a,b   Takeda, Shunichi ^a,b   Takahashi, Ryosuke ^a  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Ammonium chloride; Autophagy; Lysosome; Medaka fish; Parkinson's disease; Tunicamycin

Indexed keywords

ALPHA SYNUCLEIN; AMMONIUM CHLORIDE; CATHEPSIN D; CATHEPSIN H; LACTACYSTIN; TUNICAMYCIN; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INCLUSION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEGRADATION; DOPAMINERGIC NERVE CELL; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GLYCOSYLATION; HUMAN; HUMAN CELL; LYSOSOME; MOTOR DYSFUNCTION; NONHUMAN; ORYZIAS; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION;

ACETYLCYSTEINE; AMMONIUM CHLORIDE; ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; NERVE TISSUE PROTEINS; NEURONS; NEUROTOXINS; ORYZIAS; PARKINSONIAN DISORDERS; PHENOTYPE; SUBSTANTIA NIGRA; TUNICAMYCIN;

ORYZIINAE;

EID: 78149239653     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.07012.x     Document Type: Article

References (35)

1. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V. and Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
2. Blandini F., Armentero M. T. and Martignoni E. (2008) The 6-hydroxydopamine model: news from the past. Parkinsonism Relat. Disord. 14(Suppl 2), S124-S129.
3. Bové J., Prou D., Perier C. and Przedborski S. (2005) Toxin-induced models of Parkinson's disease. NeuroRx 2, 484-494.
4. Brooks A. I., Chadwick C. A., Gelbard H. A., Cory-Slechta D. A. and Federoff H. J. (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 823, 1-10.
5. Ciechanover A. (2005) Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat. Rev. Mol. Cell Biol. 6, 79-87.
6. Crews L., Spencer B., Desplats P., Patrick C., Paulino A., Rockenstein E., Hansen L., Adame A., Galasko D. and Masliah E. (2010) Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS ONE 5, e9313.
7. Cuervo A. M., Stefanis L., Fredenburg R., Lansbury P. T. and Sulzer D. (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292-1295.
8. Dauer W. and Przedborski S. (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889-909.
9. Fornai F., Schlüter O. M., Lenzi P. et al. (2005) Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc. Natl Acad. Sci. USA 102, 3413-3418.
10. Geisler S., Holmström K. M., Skujat D., Fiesel F. C., Rothfuss O. C., Kahle P. J. and Springer W. (2010) PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 12, 119-131.
11. Iwatsubo T. (2003) Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease. J. Neurol. 250(Suppl 3), III11-III14.
12. Jonsson G. (1983) Chemical lesioning techniques: monoamine neurotoxins, in Handbook of Chemical Neuroanatomy. Methods in Chemical Neuroanatomy (Björklund A. and Hökfelt T., eds), Edn 1, Vol. 1, pp. 463-507. Elsevier Science Publishers B.V, Amsterdam.
13. Kawajiri S., Saiki S., Sato S., Sato F., Hatano T., Eguchi H. and Hattori N.. (2010) PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy. FEBS Lett. 584, 1073-1079.
14. Komatsu M., Waguri S., Chiba T. et al. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880-884.
15. Kopin I. J. (1987) MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease. Environ. Health Perspect. 75, 45-51.
16. Krebiehl G., Ruckerbauer S., Burbulla L. F. et al. (2010) Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1. PLoS ONE 5, e9367.
17. Matsuda N., Sato S., Shiba K. et al. (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J. Cell Biol. 189, 211-221.
18. Matsui H., Taniguchi Y., Inoue H., Uemura K., Takeda S. and Takahashi R. (2009) A chemical neurotoxin, MPTP induces Parkinson's disease like phenotype, movement disorders and persistent loss of dopamine neurons in medaka fish. Neurosci. Res. 65, 263-271.
19. Matsui H., Taniguchi Y., Inoue H., Kobayashi Y., Sakaki Y., Toyoda A., Uemura K., Kobayashi D., Takeda S. and Takahashi R. (2010a) Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement. Neurosci. Res. 66, 151-161.
20. Matsui H., Ito H., Taniguchi Y., Inoue H., Takeda S. and Takahashi R. (2010b) Proteasome inhibition in medaka brain induces the features of Parkinson disease. J. Neurochem. 115, 178-187.
21. McNaught K. S., Perl D. P., Brownell A. L. and Olanow C. W. (2004) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann. Neurol. 56, 149-162.
22. Michiorri S., Gelmetti V., Giarda E. et al. (2010) The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ. 17, 962-974.
23. Narendra D., Tanaka A., Suen D. F. and Youle R. J. (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795-803.
24. Narendra D. P., Jin S. M., Tanaka A., Suen D. F., Gautier C. A., Shen J., Cookson M. R. and Youle R. J. (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 8, e1000298.
25. Ohkuma S. and Poole B. (1981) Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J. Cell Biol. 90, 656-664.
26. Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
27. Saito Y., Suzuki K., Hulette C. M. and Murayama S. (2004) Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease. J. Neuropathol. Exp. Neurol. 63, 323-328.
28. Schober A. (2004) Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 318, 215-224.
29. Smeyne R. J. and Jackson-Lewis V. (2005) The MPTP model of Parkinson's disease. Brain Res. Mol. Brain Res. 134, 57-66.
30. Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R. and Goedert M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839-840.
31. Tayebi N., Callahan M., Madike V., Stubblefield B. K., Orvisky E., Krasnewich D., Fillano J. J. and Sidransky E. (2001) Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol. Genet. Metab. 73, 313-321.
32. Uversky V. N. (2004) Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res. 318, 225-241.
33. Várkonyi J., Rosenbaum H., Baumann N., MacKenzie J. J., Simon Z., Aharon-Peretz J., Walker J. M., Tayebi N. and Sidransky E. (2003) Gaucher disease associated with parkinsonism: four further case reports. Am. J. Med. Genet. A 116, 348-351.
34. Vives-Bauza C., Zhou C., Huang Y. et al. (2010) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl Acad. Sci. USA 107, 378-383.
35. Warner T. T. and Schapira A. H. (2003) Genetic and environmental factors in the cause of Parkinson's disease. Ann. Neurol. 53(Suppl 3), S16-S23.